Entasis Therapeutics - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsEntasis Therapeutics

Entasis Therapeutics(ETTX)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Xacduro	Durlobactam, Sulbactam	2023-05-23	2033-2035	Respiratory tract infections , Urinary tract infections , Pneumococcal infections , Infectious pregnancy complications , Bacterial infections , Gonorrhea , Intraabdominal infections , Bacterial skin diseases , Escherichia coli infections , Soft tissue infections , Bacillary dysentery , Surgical wound infection , Staphylococcal infections , Bacterial endocarditis , Bacterial meningitis , Salmonella infections , Proteus infections , Acinetobacter infections , Listeriosis , Klebsiella infections , Meningococcal infections , Haemophilus infections , Human bites , Actinomycosis

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

renal insufficiency

,

healthy volunteers/patients

,

,

urinary tract infections

,

communicable diseases

,

,

ventilator-associated pneumonia

,

iatrogenic disease

,

,

bacterial pneumonia

,

,

acinetobacter infections

renal insufficiency

,

healthy volunteers/patients

,

,

urinary tract infections

,

communicable diseases

,

,

acinetobacter infections

,

ventilator-associated pneumonia

,

iatrogenic disease

,

,

bacterial pneumonia

,

healthy volunteers/patients

healthcare-associated pneumonia

,

,

type 2 diabetes mellitus

,

diabetes mellitus

,

,

communicable diseases

,

urinary tract infections

,

bacterial infections

,

,

bacterial pneumonia

,

gram-negative bacterial infections

,

,

non-hodgkin lymphoma

,

,

b-cell chronic lymphocytic leukemia

,

mantle-cell lymphoma

,

large b-cell lymphoma diffuse

Sodium chloride

healthy volunteers/patients

,

atherosclerosis

,

,

,

chronic hepatitis b

,

communicable diseases

,

,

,

herpesviridae infections

,

,

,

idiopathic pulmonary fibrosis

,

pulmonary fibrosis

,

,

subarachnoid hemorrhage

,

malignant mesothelioma

,

,

non-hodgkin lymphoma

,

,

large b-cell lymphoma diffuse

,

b-cell lymphoma

,

colorectal neoplasms

,

uterine cervical neoplasms

,

,

thrombocytopenic purpura idiopathic

,

thrombocytopenic purpura

,

,

,

transitional cell carcinoma

,

multiple sclerosis

,

,

rheumatoid arthritis

,

,

relapsing-remitting multiple sclerosis

,

,

chronic progressive multiple sclerosis

,

ulcerative colitis

,

,

,

,

pleural empyema

,

,

graft rejection

,

giant cell arteritis

,

polymyalgia rheumatica

,

kidney transplantation

,

,

drug-related side effects and adverse reactions

,

renal insufficiency

,

,

,

,

,

,

,

cardiovascular diseases

,

health risk behaviors

,

vascular stiffness

healthy volunteers/patients

,

therapeutic equivalency

healthy volunteers/patients

,

hypercholesterolemia

,

staphylococcal infections

,

renal insufficiency

,

chronic renal insufficiency

,

type 2 diabetes mellitus

,

diabetes mellitus

,

chronic kidney failure

,

kidney diseases

,

,

,

chronic hepatitis c

,

,

,

communicable diseases

,

chronic hepatitis

,

ventilator-associated pneumonia

,

,

,

communicable diseases

,

intraabdominal infections

,

healthcare-associated pneumonia

,

urinary tract infections

,

,

bacterial infections

,

bacillary dysentery

,

,

,

,

ventilator-associated pneumonia

,

,

,

cystic fibrosis

,

pseudomonas aeruginosa

renal insufficiency

,

,

urinary tract infections

,

communicable diseases

,

,

healthy volunteers/patients

,

,

acquired immunodeficiency syndrome

,

,

chronic hepatitis c

,

systemic lupus erythematosus

,

alzheimer disease

© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use